8-104497472-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The ENST00000276654.10(LRP12):āc.1080T>Cā(p.Asn360=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00766 in 1,614,148 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0046 ( 3 hom., cov: 32)
Exomes š: 0.0080 ( 56 hom. )
Consequence
LRP12
ENST00000276654.10 synonymous
ENST00000276654.10 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.211
Genes affected
LRP12 (HGNC:31708): (LDL receptor related protein 12) This gene encodes a member of the low-density lipoprotein receptor related protein family. The product of this gene is a transmembrane protein that is differentially expressed in many cancer cells. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 8-104497472-A-G is Benign according to our data. Variant chr8-104497472-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 1335717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.211 with no splicing effect.
BS2
High AC in GnomAd4 at 701 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRP12 | NM_013437.5 | c.1080T>C | p.Asn360= | synonymous_variant | 5/7 | ENST00000276654.10 | NP_038465.1 | |
LRP12 | NM_001135703.3 | c.1023T>C | p.Asn341= | synonymous_variant | 4/6 | NP_001129175.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRP12 | ENST00000276654.10 | c.1080T>C | p.Asn360= | synonymous_variant | 5/7 | 1 | NM_013437.5 | ENSP00000276654 | P4 | |
LRP12 | ENST00000424843.6 | c.1023T>C | p.Asn341= | synonymous_variant | 4/6 | 2 | ENSP00000399148 | A1 | ||
LRP12 | ENST00000523007.1 | c.-154T>C | 5_prime_UTR_variant | 1/3 | 2 | ENSP00000429305 |
Frequencies
GnomAD3 genomes AF: 0.00461 AC: 701AN: 152170Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
701
AN:
152170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00491 AC: 1235AN: 251310Hom.: 5 AF XY: 0.00476 AC XY: 646AN XY: 135814
GnomAD3 exomes
AF:
AC:
1235
AN:
251310
Hom.:
AF XY:
AC XY:
646
AN XY:
135814
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00798 AC: 11660AN: 1461860Hom.: 56 Cov.: 32 AF XY: 0.00779 AC XY: 5664AN XY: 727230
GnomAD4 exome
AF:
AC:
11660
AN:
1461860
Hom.:
Cov.:
32
AF XY:
AC XY:
5664
AN XY:
727230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00460 AC: 701AN: 152288Hom.: 3 Cov.: 32 AF XY: 0.00436 AC XY: 325AN XY: 74468
GnomAD4 genome
AF:
AC:
701
AN:
152288
Hom.:
Cov.:
32
AF XY:
AC XY:
325
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | LRP12: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at